Global Liver Cancer Treatment Drug Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Liver Cancer Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Cancer Treatment Drug.
The Liver Cancer Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Liver Cancer Treatment Drug market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liver Cancer Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liver Cancer Treatment Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Liver Cancer Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Liver Cancer Treatment Drug market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liver Cancer Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- 4SC AG
- Alnylam Pharmaceuticals, Inc.
- AVEO Pharmaceuticals, Inc
- Bayer AG
- Becton, Dickinson and Co.
- Bristol-Myers Squibb Co.
- Celsion Corp.
- Dicerna Pharmaceuticals, Inc.
- Eli Lilly and Co.
- Exelixis, Inc.
- F. Hoffmann-La Roche, Ltd.
- FibroGen, Inc.
- General Electric Co.(GE Healthcare)
- Merck & Co., Inc.(ArQule, Inc.)
- Novartis International AG
- Nymox Corp.
- Pfizer, Inc.
- SMC Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- Targeted Therapy
- Radiation Therapy
- Immunotherapy
- Chemotherapy
- Other
- Hepatocellular Carcinoma
- Cholangio Carcinoma
- Hepatoblastoma
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liver Cancer Treatment Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liver Cancer Treatment Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Targeted Therapy
1.2.3 Radiation Therapy
1.2.4 Immunotherapy
1.2.5 Chemotherapy
1.2.6 Other
1.3 Market by Application
1.3.1 Global Liver Cancer Treatment Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hepatocellular Carcinoma
1.3.3 Cholangio Carcinoma
1.3.4 Hepatoblastoma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Liver Cancer Treatment Drug Market Perspective (2018-2029)
2.2 Liver Cancer Treatment Drug Growth Trends by Region
2.2.1 Global Liver Cancer Treatment Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Liver Cancer Treatment Drug Historic Market Size by Region (2018-2023)
2.2.3 Liver Cancer Treatment Drug Forecasted Market Size by Region (2024-2029)
2.3 Liver Cancer Treatment Drug Market Dynamics
2.3.1 Liver Cancer Treatment Drug Industry Trends
2.3.2 Liver Cancer Treatment Drug Market Drivers
2.3.3 Liver Cancer Treatment Drug Market Challenges
2.3.4 Liver Cancer Treatment Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Liver Cancer Treatment Drug Players by Revenue
3.1.1 Global Top Liver Cancer Treatment Drug Players by Revenue (2018-2023)
3.1.2 Global Liver Cancer Treatment Drug Revenue Market Share by Players (2018-2023)
3.2 Global Liver Cancer Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liver Cancer Treatment Drug Revenue
3.4 Global Liver Cancer Treatment Drug Market Concentration Ratio
3.4.1 Global Liver Cancer Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Cancer Treatment Drug Revenue in 2022
3.5 Liver Cancer Treatment Drug Key Players Head office and Area Served
3.6 Key Players Liver Cancer Treatment Drug Product Solution and Service
3.7 Date of Enter into Liver Cancer Treatment Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 LIVER CANCER TREATMENT DRUG BREAKDOWN DATA BY TYPE
4.1 Global Liver Cancer Treatment Drug Historic Market Size by Type (2018-2023)
4.2 Global Liver Cancer Treatment Drug Forecasted Market Size by Type (2024-2029)
5 LIVER CANCER TREATMENT DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global Liver Cancer Treatment Drug Historic Market Size by Application (2018-2023)
5.2 Global Liver Cancer Treatment Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Liver Cancer Treatment Drug Market Size (2018-2029)
6.2 North America Liver Cancer Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Liver Cancer Treatment Drug Market Size by Country (2018-2023)
6.4 North America Liver Cancer Treatment Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Liver Cancer Treatment Drug Market Size (2018-2029)
7.2 Europe Liver Cancer Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Liver Cancer Treatment Drug Market Size by Country (2018-2023)
7.4 Europe Liver Cancer Treatment Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Liver Cancer Treatment Drug Market Size (2018-2029)
8.2 Asia-Pacific Liver Cancer Treatment Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Liver Cancer Treatment Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Liver Cancer Treatment Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Liver Cancer Treatment Drug Market Size (2018-2029)
9.2 Latin America Liver Cancer Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Liver Cancer Treatment Drug Market Size by Country (2018-2023)
9.4 Latin America Liver Cancer Treatment Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Liver Cancer Treatment Drug Market Size (2018-2029)
10.2 Middle East & Africa Liver Cancer Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Liver Cancer Treatment Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Liver Cancer Treatment Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 4SC AG
11.1.1 4SC AG Company Detail
11.1.2 4SC AG Business Overview
11.1.3 4SC AG Liver Cancer Treatment Drug Introduction
11.1.4 4SC AG Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.1.5 4SC AG Recent Development
11.2 Alnylam Pharmaceuticals, Inc.
11.2.1 Alnylam Pharmaceuticals, Inc. Company Detail
11.2.2 Alnylam Pharmaceuticals, Inc. Business Overview
11.2.3 Alnylam Pharmaceuticals, Inc. Liver Cancer Treatment Drug Introduction
11.2.4 Alnylam Pharmaceuticals, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.2.5 Alnylam Pharmaceuticals, Inc. Recent Development
11.3 AVEO Pharmaceuticals, Inc
11.3.1 AVEO Pharmaceuticals, Inc Company Detail
11.3.2 AVEO Pharmaceuticals, Inc Business Overview
11.3.3 AVEO Pharmaceuticals, Inc Liver Cancer Treatment Drug Introduction
11.3.4 AVEO Pharmaceuticals, Inc Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.3.5 AVEO Pharmaceuticals, Inc Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Detail
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Liver Cancer Treatment Drug Introduction
11.4.4 Bayer AG Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.4.5 Bayer AG Recent Development
11.5 Becton, Dickinson and Co.
11.5.1 Becton, Dickinson and Co. Company Detail
11.5.2 Becton, Dickinson and Co. Business Overview
11.5.3 Becton, Dickinson and Co. Liver Cancer Treatment Drug Introduction
11.5.4 Becton, Dickinson and Co. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.5.5 Becton, Dickinson and Co. Recent Development
11.6 Bristol-Myers Squibb Co.
11.6.1 Bristol-Myers Squibb Co. Company Detail
11.6.2 Bristol-Myers Squibb Co. Business Overview
11.6.3 Bristol-Myers Squibb Co. Liver Cancer Treatment Drug Introduction
11.6.4 Bristol-Myers Squibb Co. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.6.5 Bristol-Myers Squibb Co. Recent Development
11.7 Celsion Corp.
11.7.1 Celsion Corp. Company Detail
11.7.2 Celsion Corp. Business Overview
11.7.3 Celsion Corp. Liver Cancer Treatment Drug Introduction
11.7.4 Celsion Corp. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.7.5 Celsion Corp. Recent Development
11.8 Dicerna Pharmaceuticals, Inc.
11.8.1 Dicerna Pharmaceuticals, Inc. Company Detail
11.8.2 Dicerna Pharmaceuticals, Inc. Business Overview
11.8.3 Dicerna Pharmaceuticals, Inc. Liver Cancer Treatment Drug Introduction
11.8.4 Dicerna Pharmaceuticals, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.8.5 Dicerna Pharmaceuticals, Inc. Recent Development
11.9 Eli Lilly and Co.
11.9.1 Eli Lilly and Co. Company Detail
11.9.2 Eli Lilly and Co. Business Overview
11.9.3 Eli Lilly and Co. Liver Cancer Treatment Drug Introduction
11.9.4 Eli Lilly and Co. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.9.5 Eli Lilly and Co. Recent Development
11.10 Exelixis, Inc.
11.10.1 Exelixis, Inc. Company Detail
11.10.2 Exelixis, Inc. Business Overview
11.10.3 Exelixis, Inc. Liver Cancer Treatment Drug Introduction
11.10.4 Exelixis, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.10.5 Exelixis, Inc. Recent Development
11.11 F. Hoffmann-La Roche, Ltd.
11.11.1 F. Hoffmann-La Roche, Ltd. Company Detail
11.11.2 F. Hoffmann-La Roche, Ltd. Business Overview
11.11.3 F. Hoffmann-La Roche, Ltd. Liver Cancer Treatment Drug Introduction
11.11.4 F. Hoffmann-La Roche, Ltd. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.11.5 F. Hoffmann-La Roche, Ltd. Recent Development
11.12 FibroGen, Inc.
11.12.1 FibroGen, Inc. Company Detail
11.12.2 FibroGen, Inc. Business Overview
11.12.3 FibroGen, Inc. Liver Cancer Treatment Drug Introduction
11.12.4 FibroGen, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.12.5 FibroGen, Inc. Recent Development
11.13 General Electric Co.(GE Healthcare)
11.13.1 General Electric Co.(GE Healthcare) Company Detail
11.13.2 General Electric Co.(GE Healthcare) Business Overview
11.13.3 General Electric Co.(GE Healthcare) Liver Cancer Treatment Drug Introduction
11.13.4 General Electric Co.(GE Healthcare) Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.13.5 General Electric Co.(GE Healthcare) Recent Development
11.14 Merck & Co., Inc.(ArQule, Inc.)
11.14.1 Merck & Co., Inc.(ArQule, Inc.) Company Detail
11.14.2 Merck & Co., Inc.(ArQule, Inc.) Business Overview
11.14.3 Merck & Co., Inc.(ArQule, Inc.) Liver Cancer Treatment Drug Introduction
11.14.4 Merck & Co., Inc.(ArQule, Inc.) Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.14.5 Merck & Co., Inc.(ArQule, Inc.) Recent Development
11.15 Novartis International AG
11.15.1 Novartis International AG Company Detail
11.15.2 Novartis International AG Business Overview
11.15.3 Novartis International AG Liver Cancer Treatment Drug Introduction
11.15.4 Novartis International AG Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.15.5 Novartis International AG Recent Development
11.16 Nymox Corp.
11.16.1 Nymox Corp. Company Detail
11.16.2 Nymox Corp. Business Overview
11.16.3 Nymox Corp. Liver Cancer Treatment Drug Introduction
11.16.4 Nymox Corp. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.16.5 Nymox Corp. Recent Development
11.17 Pfizer, Inc.
11.17.1 Pfizer, Inc. Company Detail
11.17.2 Pfizer, Inc. Business Overview
11.17.3 Pfizer, Inc. Liver Cancer Treatment Drug Introduction
11.17.4 Pfizer, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.17.5 Pfizer, Inc. Recent Development
11.18 SMC Laboratories, Inc.
11.18.1 SMC Laboratories, Inc. Company Detail
11.18.2 SMC Laboratories, Inc. Business Overview
11.18.3 SMC Laboratories, Inc. Liver Cancer Treatment Drug Introduction
11.18.4 SMC Laboratories, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.18.5 SMC Laboratories, Inc. Recent Development
11.19 Thermo Fisher Scientific, Inc.
11.19.1 Thermo Fisher Scientific, Inc. Company Detail
11.19.2 Thermo Fisher Scientific, Inc. Business Overview
11.19.3 Thermo Fisher Scientific, Inc. Liver Cancer Treatment Drug Introduction
11.19.4 Thermo Fisher Scientific, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.19.5 Thermo Fisher Scientific, Inc. Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liver Cancer Treatment Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Targeted Therapy
1.2.3 Radiation Therapy
1.2.4 Immunotherapy
1.2.5 Chemotherapy
1.2.6 Other
1.3 Market by Application
1.3.1 Global Liver Cancer Treatment Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hepatocellular Carcinoma
1.3.3 Cholangio Carcinoma
1.3.4 Hepatoblastoma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Liver Cancer Treatment Drug Market Perspective (2018-2029)
2.2 Liver Cancer Treatment Drug Growth Trends by Region
2.2.1 Global Liver Cancer Treatment Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Liver Cancer Treatment Drug Historic Market Size by Region (2018-2023)
2.2.3 Liver Cancer Treatment Drug Forecasted Market Size by Region (2024-2029)
2.3 Liver Cancer Treatment Drug Market Dynamics
2.3.1 Liver Cancer Treatment Drug Industry Trends
2.3.2 Liver Cancer Treatment Drug Market Drivers
2.3.3 Liver Cancer Treatment Drug Market Challenges
2.3.4 Liver Cancer Treatment Drug Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Liver Cancer Treatment Drug Players by Revenue
3.1.1 Global Top Liver Cancer Treatment Drug Players by Revenue (2018-2023)
3.1.2 Global Liver Cancer Treatment Drug Revenue Market Share by Players (2018-2023)
3.2 Global Liver Cancer Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liver Cancer Treatment Drug Revenue
3.4 Global Liver Cancer Treatment Drug Market Concentration Ratio
3.4.1 Global Liver Cancer Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Cancer Treatment Drug Revenue in 2022
3.5 Liver Cancer Treatment Drug Key Players Head office and Area Served
3.6 Key Players Liver Cancer Treatment Drug Product Solution and Service
3.7 Date of Enter into Liver Cancer Treatment Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 LIVER CANCER TREATMENT DRUG BREAKDOWN DATA BY TYPE
4.1 Global Liver Cancer Treatment Drug Historic Market Size by Type (2018-2023)
4.2 Global Liver Cancer Treatment Drug Forecasted Market Size by Type (2024-2029)
5 LIVER CANCER TREATMENT DRUG BREAKDOWN DATA BY APPLICATION
5.1 Global Liver Cancer Treatment Drug Historic Market Size by Application (2018-2023)
5.2 Global Liver Cancer Treatment Drug Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Liver Cancer Treatment Drug Market Size (2018-2029)
6.2 North America Liver Cancer Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Liver Cancer Treatment Drug Market Size by Country (2018-2023)
6.4 North America Liver Cancer Treatment Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Liver Cancer Treatment Drug Market Size (2018-2029)
7.2 Europe Liver Cancer Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Liver Cancer Treatment Drug Market Size by Country (2018-2023)
7.4 Europe Liver Cancer Treatment Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Liver Cancer Treatment Drug Market Size (2018-2029)
8.2 Asia-Pacific Liver Cancer Treatment Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Liver Cancer Treatment Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Liver Cancer Treatment Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Liver Cancer Treatment Drug Market Size (2018-2029)
9.2 Latin America Liver Cancer Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Liver Cancer Treatment Drug Market Size by Country (2018-2023)
9.4 Latin America Liver Cancer Treatment Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Liver Cancer Treatment Drug Market Size (2018-2029)
10.2 Middle East & Africa Liver Cancer Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Liver Cancer Treatment Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Liver Cancer Treatment Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 4SC AG
11.1.1 4SC AG Company Detail
11.1.2 4SC AG Business Overview
11.1.3 4SC AG Liver Cancer Treatment Drug Introduction
11.1.4 4SC AG Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.1.5 4SC AG Recent Development
11.2 Alnylam Pharmaceuticals, Inc.
11.2.1 Alnylam Pharmaceuticals, Inc. Company Detail
11.2.2 Alnylam Pharmaceuticals, Inc. Business Overview
11.2.3 Alnylam Pharmaceuticals, Inc. Liver Cancer Treatment Drug Introduction
11.2.4 Alnylam Pharmaceuticals, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.2.5 Alnylam Pharmaceuticals, Inc. Recent Development
11.3 AVEO Pharmaceuticals, Inc
11.3.1 AVEO Pharmaceuticals, Inc Company Detail
11.3.2 AVEO Pharmaceuticals, Inc Business Overview
11.3.3 AVEO Pharmaceuticals, Inc Liver Cancer Treatment Drug Introduction
11.3.4 AVEO Pharmaceuticals, Inc Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.3.5 AVEO Pharmaceuticals, Inc Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Detail
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Liver Cancer Treatment Drug Introduction
11.4.4 Bayer AG Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.4.5 Bayer AG Recent Development
11.5 Becton, Dickinson and Co.
11.5.1 Becton, Dickinson and Co. Company Detail
11.5.2 Becton, Dickinson and Co. Business Overview
11.5.3 Becton, Dickinson and Co. Liver Cancer Treatment Drug Introduction
11.5.4 Becton, Dickinson and Co. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.5.5 Becton, Dickinson and Co. Recent Development
11.6 Bristol-Myers Squibb Co.
11.6.1 Bristol-Myers Squibb Co. Company Detail
11.6.2 Bristol-Myers Squibb Co. Business Overview
11.6.3 Bristol-Myers Squibb Co. Liver Cancer Treatment Drug Introduction
11.6.4 Bristol-Myers Squibb Co. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.6.5 Bristol-Myers Squibb Co. Recent Development
11.7 Celsion Corp.
11.7.1 Celsion Corp. Company Detail
11.7.2 Celsion Corp. Business Overview
11.7.3 Celsion Corp. Liver Cancer Treatment Drug Introduction
11.7.4 Celsion Corp. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.7.5 Celsion Corp. Recent Development
11.8 Dicerna Pharmaceuticals, Inc.
11.8.1 Dicerna Pharmaceuticals, Inc. Company Detail
11.8.2 Dicerna Pharmaceuticals, Inc. Business Overview
11.8.3 Dicerna Pharmaceuticals, Inc. Liver Cancer Treatment Drug Introduction
11.8.4 Dicerna Pharmaceuticals, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.8.5 Dicerna Pharmaceuticals, Inc. Recent Development
11.9 Eli Lilly and Co.
11.9.1 Eli Lilly and Co. Company Detail
11.9.2 Eli Lilly and Co. Business Overview
11.9.3 Eli Lilly and Co. Liver Cancer Treatment Drug Introduction
11.9.4 Eli Lilly and Co. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.9.5 Eli Lilly and Co. Recent Development
11.10 Exelixis, Inc.
11.10.1 Exelixis, Inc. Company Detail
11.10.2 Exelixis, Inc. Business Overview
11.10.3 Exelixis, Inc. Liver Cancer Treatment Drug Introduction
11.10.4 Exelixis, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.10.5 Exelixis, Inc. Recent Development
11.11 F. Hoffmann-La Roche, Ltd.
11.11.1 F. Hoffmann-La Roche, Ltd. Company Detail
11.11.2 F. Hoffmann-La Roche, Ltd. Business Overview
11.11.3 F. Hoffmann-La Roche, Ltd. Liver Cancer Treatment Drug Introduction
11.11.4 F. Hoffmann-La Roche, Ltd. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.11.5 F. Hoffmann-La Roche, Ltd. Recent Development
11.12 FibroGen, Inc.
11.12.1 FibroGen, Inc. Company Detail
11.12.2 FibroGen, Inc. Business Overview
11.12.3 FibroGen, Inc. Liver Cancer Treatment Drug Introduction
11.12.4 FibroGen, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.12.5 FibroGen, Inc. Recent Development
11.13 General Electric Co.(GE Healthcare)
11.13.1 General Electric Co.(GE Healthcare) Company Detail
11.13.2 General Electric Co.(GE Healthcare) Business Overview
11.13.3 General Electric Co.(GE Healthcare) Liver Cancer Treatment Drug Introduction
11.13.4 General Electric Co.(GE Healthcare) Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.13.5 General Electric Co.(GE Healthcare) Recent Development
11.14 Merck & Co., Inc.(ArQule, Inc.)
11.14.1 Merck & Co., Inc.(ArQule, Inc.) Company Detail
11.14.2 Merck & Co., Inc.(ArQule, Inc.) Business Overview
11.14.3 Merck & Co., Inc.(ArQule, Inc.) Liver Cancer Treatment Drug Introduction
11.14.4 Merck & Co., Inc.(ArQule, Inc.) Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.14.5 Merck & Co., Inc.(ArQule, Inc.) Recent Development
11.15 Novartis International AG
11.15.1 Novartis International AG Company Detail
11.15.2 Novartis International AG Business Overview
11.15.3 Novartis International AG Liver Cancer Treatment Drug Introduction
11.15.4 Novartis International AG Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.15.5 Novartis International AG Recent Development
11.16 Nymox Corp.
11.16.1 Nymox Corp. Company Detail
11.16.2 Nymox Corp. Business Overview
11.16.3 Nymox Corp. Liver Cancer Treatment Drug Introduction
11.16.4 Nymox Corp. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.16.5 Nymox Corp. Recent Development
11.17 Pfizer, Inc.
11.17.1 Pfizer, Inc. Company Detail
11.17.2 Pfizer, Inc. Business Overview
11.17.3 Pfizer, Inc. Liver Cancer Treatment Drug Introduction
11.17.4 Pfizer, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.17.5 Pfizer, Inc. Recent Development
11.18 SMC Laboratories, Inc.
11.18.1 SMC Laboratories, Inc. Company Detail
11.18.2 SMC Laboratories, Inc. Business Overview
11.18.3 SMC Laboratories, Inc. Liver Cancer Treatment Drug Introduction
11.18.4 SMC Laboratories, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.18.5 SMC Laboratories, Inc. Recent Development
11.19 Thermo Fisher Scientific, Inc.
11.19.1 Thermo Fisher Scientific, Inc. Company Detail
11.19.2 Thermo Fisher Scientific, Inc. Business Overview
11.19.3 Thermo Fisher Scientific, Inc. Liver Cancer Treatment Drug Introduction
11.19.4 Thermo Fisher Scientific, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023)
11.19.5 Thermo Fisher Scientific, Inc. Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Liver Cancer Treatment Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Targeted Therapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Immunotherapy
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Other
Table 7. Global Liver Cancer Treatment Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Liver Cancer Treatment Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Liver Cancer Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Liver Cancer Treatment Drug Market Share by Region (2018-2023)
Table 11. Global Liver Cancer Treatment Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Liver Cancer Treatment Drug Market Share by Region (2024-2029)
Table 13. Liver Cancer Treatment Drug Market Trends
Table 14. Liver Cancer Treatment Drug Market Drivers
Table 15. Liver Cancer Treatment Drug Market Challenges
Table 16. Liver Cancer Treatment Drug Market Restraints
Table 17. Global Liver Cancer Treatment Drug Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Liver Cancer Treatment Drug Market Share by Players (2018-2023)
Table 19. Global Top Liver Cancer Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cancer Treatment Drug as of 2022)
Table 20. Ranking of Global Top Liver Cancer Treatment Drug Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Liver Cancer Treatment Drug Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Liver Cancer Treatment Drug Product Solution and Service
Table 24. Date of Enter into Liver Cancer Treatment Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Liver Cancer Treatment Drug Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Liver Cancer Treatment Drug Revenue Market Share by Type (2018-2023)
Table 28. Global Liver Cancer Treatment Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Liver Cancer Treatment Drug Revenue Market Share by Type (2024-2029)
Table 30. Global Liver Cancer Treatment Drug Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Liver Cancer Treatment Drug Revenue Market Share by Application (2018-2023)
Table 32. Global Liver Cancer Treatment Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Liver Cancer Treatment Drug Revenue Market Share by Application (2024-2029)
Table 34. North America Liver Cancer Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Liver Cancer Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Liver Cancer Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Liver Cancer Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Liver Cancer Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Liver Cancer Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Liver Cancer Treatment Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Liver Cancer Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Liver Cancer Treatment Drug Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Liver Cancer Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Liver Cancer Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Liver Cancer Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Liver Cancer Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Liver Cancer Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Liver Cancer Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 49. 4SC AG Company Detail
Table 50. 4SC AG Business Overview
Table 51. 4SC AG Liver Cancer Treatment Drug Product
Table 52. 4SC AG Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 53. 4SC AG Recent Development
Table 54. Alnylam Pharmaceuticals, Inc. Company Detail
Table 55. Alnylam Pharmaceuticals, Inc. Business Overview
Table 56. Alnylam Pharmaceuticals, Inc. Liver Cancer Treatment Drug Product
Table 57. Alnylam Pharmaceuticals, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 58. Alnylam Pharmaceuticals, Inc. Recent Development
Table 59. AVEO Pharmaceuticals, Inc Company Detail
Table 60. AVEO Pharmaceuticals, Inc Business Overview
Table 61. AVEO Pharmaceuticals, Inc Liver Cancer Treatment Drug Product
Table 62. AVEO Pharmaceuticals, Inc Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 63. AVEO Pharmaceuticals, Inc Recent Development
Table 64. Bayer AG Company Detail
Table 65. Bayer AG Business Overview
Table 66. Bayer AG Liver Cancer Treatment Drug Product
Table 67. Bayer AG Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 68. Bayer AG Recent Development
Table 69. Becton, Dickinson and Co. Company Detail
Table 70. Becton, Dickinson and Co. Business Overview
Table 71. Becton, Dickinson and Co. Liver Cancer Treatment Drug Product
Table 72. Becton, Dickinson and Co. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 73. Becton, Dickinson and Co. Recent Development
Table 74. Bristol-Myers Squibb Co. Company Detail
Table 75. Bristol-Myers Squibb Co. Business Overview
Table 76. Bristol-Myers Squibb Co. Liver Cancer Treatment Drug Product
Table 77. Bristol-Myers Squibb Co. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 78. Bristol-Myers Squibb Co. Recent Development
Table 79. Celsion Corp. Company Detail
Table 80. Celsion Corp. Business Overview
Table 81. Celsion Corp. Liver Cancer Treatment Drug Product
Table 82. Celsion Corp. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 83. Celsion Corp. Recent Development
Table 84. Dicerna Pharmaceuticals, Inc. Company Detail
Table 85. Dicerna Pharmaceuticals, Inc. Business Overview
Table 86. Dicerna Pharmaceuticals, Inc. Liver Cancer Treatment Drug Product
Table 87. Dicerna Pharmaceuticals, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 88. Dicerna Pharmaceuticals, Inc. Recent Development
Table 89. Eli Lilly and Co. Company Detail
Table 90. Eli Lilly and Co. Business Overview
Table 91. Eli Lilly and Co. Liver Cancer Treatment Drug Product
Table 92. Eli Lilly and Co. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 93. Eli Lilly and Co. Recent Development
Table 94. Exelixis, Inc. Company Detail
Table 95. Exelixis, Inc. Business Overview
Table 96. Exelixis, Inc. Liver Cancer Treatment Drug Product
Table 97. Exelixis, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 98. Exelixis, Inc. Recent Development
Table 99. F. Hoffmann-La Roche, Ltd. Company Detail
Table 100. F. Hoffmann-La Roche, Ltd. Business Overview
Table 101. F. Hoffmann-La Roche, Ltd. Liver Cancer Treatment Drug Product
Table 102. F. Hoffmann-La Roche, Ltd. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 103. F. Hoffmann-La Roche, Ltd. Recent Development
Table 104. FibroGen, Inc. Company Detail
Table 105. FibroGen, Inc. Business Overview
Table 106. FibroGen, Inc. Liver Cancer Treatment Drug Product
Table 107. FibroGen, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 108. FibroGen, Inc. Recent Development
Table 109. General Electric Co.(GE Healthcare) Company Detail
Table 110. General Electric Co.(GE Healthcare) Business Overview
Table 111. General Electric Co.(GE Healthcare) Liver Cancer Treatment Drug Product
Table 112. General Electric Co.(GE Healthcare) Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 113. General Electric Co.(GE Healthcare) Recent Development
Table 114. Merck & Co., Inc.(ArQule, Inc.) Company Detail
Table 115. Merck & Co., Inc.(ArQule, Inc.) Business Overview
Table 116. Merck & Co., Inc.(ArQule, Inc.) Liver Cancer Treatment Drug Product
Table 117. Merck & Co., Inc.(ArQule, Inc.) Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 118. Merck & Co., Inc.(ArQule, Inc.) Recent Development
Table 119. Novartis International AG Company Detail
Table 120. Novartis International AG Business Overview
Table 121. Novartis International AG Liver Cancer Treatment Drug Product
Table 122. Novartis International AG Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 123. Novartis International AG Recent Development
Table 124. Nymox Corp. Company Detail
Table 125. Nymox Corp. Business Overview
Table 126. Nymox Corp. Liver Cancer Treatment Drug Product
Table 127. Nymox Corp. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 128. Nymox Corp. Recent Development
Table 129. Pfizer, Inc. Company Detail
Table 130. Pfizer, Inc. Business Overview
Table 131. Pfizer, Inc. Liver Cancer Treatment Drug Product
Table 132. Pfizer, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 133. Pfizer, Inc. Recent Development
Table 134. SMC Laboratories, Inc. Company Detail
Table 135. SMC Laboratories, Inc. Business Overview
Table 136. SMC Laboratories, Inc. Liver Cancer Treatment Drug Product
Table 137. SMC Laboratories, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 138. SMC Laboratories, Inc. Recent Development
Table 139. Thermo Fisher Scientific, Inc. Company Detail
Table 140. Thermo Fisher Scientific, Inc. Business Overview
Table 141. Thermo Fisher Scientific, Inc. Liver Cancer Treatment Drug Product
Table 142. Thermo Fisher Scientific, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 143. Thermo Fisher Scientific, Inc. Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
Table 1. Global Liver Cancer Treatment Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Targeted Therapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Immunotherapy
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Other
Table 7. Global Liver Cancer Treatment Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Liver Cancer Treatment Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Liver Cancer Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Liver Cancer Treatment Drug Market Share by Region (2018-2023)
Table 11. Global Liver Cancer Treatment Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Liver Cancer Treatment Drug Market Share by Region (2024-2029)
Table 13. Liver Cancer Treatment Drug Market Trends
Table 14. Liver Cancer Treatment Drug Market Drivers
Table 15. Liver Cancer Treatment Drug Market Challenges
Table 16. Liver Cancer Treatment Drug Market Restraints
Table 17. Global Liver Cancer Treatment Drug Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Liver Cancer Treatment Drug Market Share by Players (2018-2023)
Table 19. Global Top Liver Cancer Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cancer Treatment Drug as of 2022)
Table 20. Ranking of Global Top Liver Cancer Treatment Drug Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Liver Cancer Treatment Drug Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Liver Cancer Treatment Drug Product Solution and Service
Table 24. Date of Enter into Liver Cancer Treatment Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Liver Cancer Treatment Drug Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Liver Cancer Treatment Drug Revenue Market Share by Type (2018-2023)
Table 28. Global Liver Cancer Treatment Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Liver Cancer Treatment Drug Revenue Market Share by Type (2024-2029)
Table 30. Global Liver Cancer Treatment Drug Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Liver Cancer Treatment Drug Revenue Market Share by Application (2018-2023)
Table 32. Global Liver Cancer Treatment Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Liver Cancer Treatment Drug Revenue Market Share by Application (2024-2029)
Table 34. North America Liver Cancer Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Liver Cancer Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Liver Cancer Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Liver Cancer Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Liver Cancer Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Liver Cancer Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Liver Cancer Treatment Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Liver Cancer Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Liver Cancer Treatment Drug Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Liver Cancer Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Liver Cancer Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Liver Cancer Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Liver Cancer Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Liver Cancer Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Liver Cancer Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 49. 4SC AG Company Detail
Table 50. 4SC AG Business Overview
Table 51. 4SC AG Liver Cancer Treatment Drug Product
Table 52. 4SC AG Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 53. 4SC AG Recent Development
Table 54. Alnylam Pharmaceuticals, Inc. Company Detail
Table 55. Alnylam Pharmaceuticals, Inc. Business Overview
Table 56. Alnylam Pharmaceuticals, Inc. Liver Cancer Treatment Drug Product
Table 57. Alnylam Pharmaceuticals, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 58. Alnylam Pharmaceuticals, Inc. Recent Development
Table 59. AVEO Pharmaceuticals, Inc Company Detail
Table 60. AVEO Pharmaceuticals, Inc Business Overview
Table 61. AVEO Pharmaceuticals, Inc Liver Cancer Treatment Drug Product
Table 62. AVEO Pharmaceuticals, Inc Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 63. AVEO Pharmaceuticals, Inc Recent Development
Table 64. Bayer AG Company Detail
Table 65. Bayer AG Business Overview
Table 66. Bayer AG Liver Cancer Treatment Drug Product
Table 67. Bayer AG Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 68. Bayer AG Recent Development
Table 69. Becton, Dickinson and Co. Company Detail
Table 70. Becton, Dickinson and Co. Business Overview
Table 71. Becton, Dickinson and Co. Liver Cancer Treatment Drug Product
Table 72. Becton, Dickinson and Co. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 73. Becton, Dickinson and Co. Recent Development
Table 74. Bristol-Myers Squibb Co. Company Detail
Table 75. Bristol-Myers Squibb Co. Business Overview
Table 76. Bristol-Myers Squibb Co. Liver Cancer Treatment Drug Product
Table 77. Bristol-Myers Squibb Co. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 78. Bristol-Myers Squibb Co. Recent Development
Table 79. Celsion Corp. Company Detail
Table 80. Celsion Corp. Business Overview
Table 81. Celsion Corp. Liver Cancer Treatment Drug Product
Table 82. Celsion Corp. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 83. Celsion Corp. Recent Development
Table 84. Dicerna Pharmaceuticals, Inc. Company Detail
Table 85. Dicerna Pharmaceuticals, Inc. Business Overview
Table 86. Dicerna Pharmaceuticals, Inc. Liver Cancer Treatment Drug Product
Table 87. Dicerna Pharmaceuticals, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 88. Dicerna Pharmaceuticals, Inc. Recent Development
Table 89. Eli Lilly and Co. Company Detail
Table 90. Eli Lilly and Co. Business Overview
Table 91. Eli Lilly and Co. Liver Cancer Treatment Drug Product
Table 92. Eli Lilly and Co. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 93. Eli Lilly and Co. Recent Development
Table 94. Exelixis, Inc. Company Detail
Table 95. Exelixis, Inc. Business Overview
Table 96. Exelixis, Inc. Liver Cancer Treatment Drug Product
Table 97. Exelixis, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 98. Exelixis, Inc. Recent Development
Table 99. F. Hoffmann-La Roche, Ltd. Company Detail
Table 100. F. Hoffmann-La Roche, Ltd. Business Overview
Table 101. F. Hoffmann-La Roche, Ltd. Liver Cancer Treatment Drug Product
Table 102. F. Hoffmann-La Roche, Ltd. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 103. F. Hoffmann-La Roche, Ltd. Recent Development
Table 104. FibroGen, Inc. Company Detail
Table 105. FibroGen, Inc. Business Overview
Table 106. FibroGen, Inc. Liver Cancer Treatment Drug Product
Table 107. FibroGen, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 108. FibroGen, Inc. Recent Development
Table 109. General Electric Co.(GE Healthcare) Company Detail
Table 110. General Electric Co.(GE Healthcare) Business Overview
Table 111. General Electric Co.(GE Healthcare) Liver Cancer Treatment Drug Product
Table 112. General Electric Co.(GE Healthcare) Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 113. General Electric Co.(GE Healthcare) Recent Development
Table 114. Merck & Co., Inc.(ArQule, Inc.) Company Detail
Table 115. Merck & Co., Inc.(ArQule, Inc.) Business Overview
Table 116. Merck & Co., Inc.(ArQule, Inc.) Liver Cancer Treatment Drug Product
Table 117. Merck & Co., Inc.(ArQule, Inc.) Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 118. Merck & Co., Inc.(ArQule, Inc.) Recent Development
Table 119. Novartis International AG Company Detail
Table 120. Novartis International AG Business Overview
Table 121. Novartis International AG Liver Cancer Treatment Drug Product
Table 122. Novartis International AG Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 123. Novartis International AG Recent Development
Table 124. Nymox Corp. Company Detail
Table 125. Nymox Corp. Business Overview
Table 126. Nymox Corp. Liver Cancer Treatment Drug Product
Table 127. Nymox Corp. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 128. Nymox Corp. Recent Development
Table 129. Pfizer, Inc. Company Detail
Table 130. Pfizer, Inc. Business Overview
Table 131. Pfizer, Inc. Liver Cancer Treatment Drug Product
Table 132. Pfizer, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 133. Pfizer, Inc. Recent Development
Table 134. SMC Laboratories, Inc. Company Detail
Table 135. SMC Laboratories, Inc. Business Overview
Table 136. SMC Laboratories, Inc. Liver Cancer Treatment Drug Product
Table 137. SMC Laboratories, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 138. SMC Laboratories, Inc. Recent Development
Table 139. Thermo Fisher Scientific, Inc. Company Detail
Table 140. Thermo Fisher Scientific, Inc. Business Overview
Table 141. Thermo Fisher Scientific, Inc. Liver Cancer Treatment Drug Product
Table 142. Thermo Fisher Scientific, Inc. Revenue in Liver Cancer Treatment Drug Business (2018-2023) & (US$ Million)
Table 143. Thermo Fisher Scientific, Inc. Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Liver Cancer Treatment Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Liver Cancer Treatment Drug Market Share by Type: 2022 VS 2029
Figure 3. Targeted Therapy Features
Figure 4. Radiation Therapy Features
Figure 5. Immunotherapy Features
Figure 6. Chemotherapy Features
Figure 7. Other Features
Figure 8. Global Liver Cancer Treatment Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Liver Cancer Treatment Drug Market Share by Application: 2022 VS 2029
Figure 10. Hepatocellular Carcinoma Case Studies
Figure 11. Cholangio Carcinoma Case Studies
Figure 12. Hepatoblastoma Case Studies
Figure 13. Other Case Studies
Figure 14. Liver Cancer Treatment Drug Report Years Considered
Figure 15. Global Liver Cancer Treatment Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Liver Cancer Treatment Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Liver Cancer Treatment Drug Market Share by Region: 2022 VS 2029
Figure 18. Global Liver Cancer Treatment Drug Market Share by Players in 2022
Figure 19. Global Top Liver Cancer Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cancer Treatment Drug as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Liver Cancer Treatment Drug Revenue in 2022
Figure 21. North America Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Liver Cancer Treatment Drug Market Share by Country (2018-2029)
Figure 23. United States Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Liver Cancer Treatment Drug Market Share by Country (2018-2029)
Figure 27. Germany Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Liver Cancer Treatment Drug Market Share by Region (2018-2029)
Figure 35. China Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Liver Cancer Treatment Drug Market Share by Country (2018-2029)
Figure 43. Mexico Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Liver Cancer Treatment Drug Market Share by Country (2018-2029)
Figure 47. Turkey Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. 4SC AG Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 50. Alnylam Pharmaceuticals, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 51. AVEO Pharmaceuticals, Inc Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 52. Bayer AG Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 53. Becton, Dickinson and Co. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 54. Bristol-Myers Squibb Co. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 55. Celsion Corp. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 56. Dicerna Pharmaceuticals, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 57. Eli Lilly and Co. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 58. Exelixis, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 59. F. Hoffmann-La Roche, Ltd. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 60. FibroGen, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 61. General Electric Co.(GE Healthcare) Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 62. Merck & Co., Inc.(ArQule, Inc.) Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 63. Novartis International AG Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 64. Nymox Corp. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 65. Pfizer, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 66. SMC Laboratories, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 67. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Figure 1. Global Liver Cancer Treatment Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Liver Cancer Treatment Drug Market Share by Type: 2022 VS 2029
Figure 3. Targeted Therapy Features
Figure 4. Radiation Therapy Features
Figure 5. Immunotherapy Features
Figure 6. Chemotherapy Features
Figure 7. Other Features
Figure 8. Global Liver Cancer Treatment Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Liver Cancer Treatment Drug Market Share by Application: 2022 VS 2029
Figure 10. Hepatocellular Carcinoma Case Studies
Figure 11. Cholangio Carcinoma Case Studies
Figure 12. Hepatoblastoma Case Studies
Figure 13. Other Case Studies
Figure 14. Liver Cancer Treatment Drug Report Years Considered
Figure 15. Global Liver Cancer Treatment Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Liver Cancer Treatment Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Liver Cancer Treatment Drug Market Share by Region: 2022 VS 2029
Figure 18. Global Liver Cancer Treatment Drug Market Share by Players in 2022
Figure 19. Global Top Liver Cancer Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cancer Treatment Drug as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Liver Cancer Treatment Drug Revenue in 2022
Figure 21. North America Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Liver Cancer Treatment Drug Market Share by Country (2018-2029)
Figure 23. United States Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Liver Cancer Treatment Drug Market Share by Country (2018-2029)
Figure 27. Germany Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Liver Cancer Treatment Drug Market Share by Region (2018-2029)
Figure 35. China Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Liver Cancer Treatment Drug Market Share by Country (2018-2029)
Figure 43. Mexico Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Liver Cancer Treatment Drug Market Share by Country (2018-2029)
Figure 47. Turkey Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Liver Cancer Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. 4SC AG Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 50. Alnylam Pharmaceuticals, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 51. AVEO Pharmaceuticals, Inc Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 52. Bayer AG Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 53. Becton, Dickinson and Co. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 54. Bristol-Myers Squibb Co. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 55. Celsion Corp. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 56. Dicerna Pharmaceuticals, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 57. Eli Lilly and Co. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 58. Exelixis, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 59. F. Hoffmann-La Roche, Ltd. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 60. FibroGen, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 61. General Electric Co.(GE Healthcare) Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 62. Merck & Co., Inc.(ArQule, Inc.) Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 63. Novartis International AG Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 64. Nymox Corp. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 65. Pfizer, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 66. SMC Laboratories, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 67. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Liver Cancer Treatment Drug Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
